Insider Transactions in Q2 2023 at Aerovate Therapeutics, Inc. (AVTE)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,283
-44.93%
|
$164,528
$16.63 P/Share
|
|
Jun 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,283
+39.96%
|
$10,283
$1.94 P/Share
|
|
Jun 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-58.31%
|
$36,000
$16.26 P/Share
|
|
Jun 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
|
May 19
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
65
-1.96%
|
$1,235
$19.5 P/Share
|
|
May 19
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
65
+1.92%
|
$65
$1.74 P/Share
|
|
May 17
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,090
-25.11%
|
$20,710
$19.59 P/Share
|
|
May 17
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,090
+20.07%
|
$1,090
$1.74 P/Share
|
|
May 08
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,284
-65.18%
|
$226,248
$22.18 P/Share
|
|
May 08
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,284
+39.96%
|
$10,284
$1.94 P/Share
|
|
May 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-32.15%
|
$47,250
$21.21 P/Share
|
|
May 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
|
May 03
2023
|
Marinus Verwijs CHIEF TECHNICAL OFFICER |
SELL
Open market or private sale
|
Direct |
759
-100.0%
|
$15,180
$20.79 P/Share
|
|
May 02
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
693
-100.0%
|
$14,553
$21.15 P/Share
|
|
May 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-95.58%
|
$300,000
$20.61 P/Share
|
|
May 01
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+48.87%
|
$30,000
$2.14 P/Share
|
|
Apr 21
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,000
-67.11%
|
$76,000
$19.5 P/Share
|
|
Apr 21
2023
|
Hunter Gillies CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+40.16%
|
$4,000
$1.74 P/Share
|
|
Apr 06
2023
|
Benjamin T Dake |
SELL
Open market or private sale
|
Direct |
10,283
-100.0%
|
$185,094
$18.17 P/Share
|
|
Apr 06
2023
|
Benjamin T Dake |
BUY
Exercise of conversion of derivative security
|
Direct |
10,283
+46.68%
|
$10,283
$1.94 P/Share
|
|
Apr 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-34.7%
|
$40,500
$18.51 P/Share
|
|
Apr 05
2023
|
Ralph Niven CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+25.83%
|
$2,250
$1.94 P/Share
|
|
Apr 03
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-80.57%
|
$285,000
$19.47 P/Share
|
|
Apr 03
2023
|
Timothy P Noyes CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$30,000
$2.14 P/Share
|